Trial Profile
Assessing the efficacy of changing to Travoprost/Timolol fixed combination, as replacement therapy in patients on prostaglandin monotherapy
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Travoprost/timolol (Primary)
- Indications Glaucoma; Ocular hypertension
- Focus Adverse reactions; Therapeutic Use
- 07 Oct 2015 New trial record
- 30 Sep 2015 Results published in the Advances in Therapy.